Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...
With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...
Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...
SCSU’s MedTech programs give students more than a degree — they open doors to an exciting field that has the power to change ...
The day after completing its latest billion-dollar deal, Boston Scientific dispatched food trucks to hand out fried chicken ...
NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...
Zacks.com on MSN4d
Medtronic (MDT) Stock Sinks As Market Gains: Here's WhyThe latest trading session saw Medtronic (MDT) ending at $87.72, denoting a -0.45% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, ...
Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Friday, November 8, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp.
Ping An Healthcare and Technology Company Limited established a strategic partnership with Medtronic (MDT) Management Co., Ltd. at the 7th ...
Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback